{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System Vancomycin (0.0625-32 \u03bcg/mL) - Streptococcus ID/AST or AST",
        "BD PhoenixM Automated Microbiology System for use with the antimicrobial agent vancomycin (0.0625-32 \u03bcg/mL) - Streptococcus ID/AST or AST only Phoenix Panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K050745",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "April 29, 2005",
    "Summary Letter Received Date": "March 22, 2005",
    "Submission Date": "March 18, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Vancomycin"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates (Gram-negative aerobic and facultative anaerobic bacteria; Gram-positive bacteria: Staphylococcus, Enterococcus, Streptococcus)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix Automated Microbiology System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Automated antimicrobial susceptibility testing"
    ],
    "Methodologies": [
        "Minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Automated system",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System Streptococcus ID/AST panels for vancomycin antimicrobial susceptibility testing",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of most Gram-negative aerobic and facultative anaerobic bacteria isolates from pure culture and most Gram-positive bacteria isolates from Staphylococcus, Enterococcus, and Streptococcus, with vancomycin added to Streptococcus ID/AST panels at concentrations of 0.0625-32 \u03bcg/mL.",
    "fda_folder": "Microbiology"
}